Literature DB >> 21513353

Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia.

Zhiyong Poon1, Dongsook Chang, Xiaoyong Zhao, Paula T Hammond.   

Abstract

Inspired by the simplicity and versatility of layer-by-layer (LbL) assembly, we applied multilayered polyelectrolyte assemblies on nanoparticles to create viable systemic delivery systems. Focusing on tumor-specific delivery, LbL nanoparticles that exhibit a pH-sensitive outer stealth layer are demonstrated to target and be retained in hypoxic tumor regions. The neutral layers shed in response to acidity to reveal a charged nanoparticle surface that is readily taken up by tumor cells. The first in vivo demonstration of this mechanism of targeting is presented, as well as an initial examination of the mechanism of uptake of the nanoparticles. We further demonstrate that this concept for tumor targeting is potentially valid for a broad range of cancers, with applicability for therapies that target hypoxic tumor tissue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513353      PMCID: PMC3125426          DOI: 10.1021/nn200876f

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  42 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

Review 2.  Long-circulating and target-specific nanoparticles: theory to practice.

Authors:  S M Moghimi; A C Hunter; J C Murray
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Wortmannin-sensitive trafficking steps in the endocytic pathway in rat liver endothelial cells.

Authors:  R Kjeken; S A Mousavi; A Brech; G Griffiths; T Berg
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles.

Authors:  Heebeom Koo; Hyejung Lee; Sojin Lee; Kyung Hyun Min; Min Sang Kim; Doo Sung Lee; Yongseok Choi; Ick Chan Kwon; Kwangmeyung Kim; Seo Young Jeong
Journal:  Chem Commun (Camb)       Date:  2010-07-09       Impact factor: 6.222

5.  Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.

Authors:  Khaled Greish
Journal:  Methods Mol Biol       Date:  2010

Review 6.  Avidin-biotin technology in targeted therapy.

Authors:  Hanna P Lesch; Minna U Kaikkonen; Jere T Pikkarainen; Seppo Ylä-Herttuala
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

Review 7.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

Review 8.  Tumor physiology and drug resistance.

Authors:  I F Tannock
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

Review 9.  The dawning era of polymer therapeutics.

Authors:  Ruth Duncan
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

Review 10.  Relevance of tumor microenvironment for progression, therapy and drug development.

Authors:  Tobias Henning; Michael Kraus; Martin Brischwein; Angela M Otto; Bernhard Wolf
Journal:  Anticancer Drugs       Date:  2004-01       Impact factor: 2.248

View more
  76 in total

Review 1.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

Review 2.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

Review 3.  Smart nanosystems: Bio-inspired technologies that interact with the host environment.

Authors:  Ester J Kwon; Justin H Lo; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

4.  Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.

Authors:  Ying Li; Yanping Lian; Lucy T Zhang; Saad M Aldousari; Hassan S Hedia; Saeed A Asiri; Wing Kam Liu
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

Review 5.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

6.  Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier.

Authors:  Jouha Min; Richard D Braatz; Paula T Hammond
Journal:  Biomaterials       Date:  2013-12-31       Impact factor: 12.479

Review 7.  Extracellularly activatable nanocarriers for drug delivery to tumors.

Authors:  Sara A Abouelmagd; Hyesun Hyun; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2014-06-20       Impact factor: 6.648

8.  Hypoxia-targeted siRNA delivery.

Authors:  F Perche; S Biswas; T Wang; L Zhu; V P Torchilin
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-19       Impact factor: 15.336

9.  Functional block copolymer nanoparticles: toward the next generation of delivery vehicles.

Authors:  Maxwell J Robb; Luke A Connal; Bongjae F Lee; Nathaniel A Lynd; Craig J Hawker
Journal:  Polym Chem       Date:  2012       Impact factor: 5.582

10.  The architecture and biological performance of drug-loaded LbL nanoparticles.

Authors:  Stephen W Morton; Zhiyong Poon; Paula T Hammond
Journal:  Biomaterials       Date:  2013-04-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.